KRANTZ THEODOR 5
5 · COGNEX CORP · Filed Feb 3, 2023
Insider Transaction Report
Form 5
COGNEX CORPCGNX
KRANTZ THEODOR
Director
Transactions
- Sale
Common Stock
2022-03-17$70.05/sh−608$42,591→ 35,500 total
Holdings
- 10,400
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (10,400 underlying) - 2,431
Restricted Stock Unit
Exercise: $0.00From: 2022-02-16Exp: 2024-02-16→ Common Stock (2,431 underlying) - 4,269
Restricted Stock Unit
Exercise: $0.00From: 2023-02-22Exp: 2025-02-22→ Common Stock (4,269 underlying) - 13,000
Non-Qualified Stock Option (right to buy)
Exercise: $56.44From: 2019-02-20Exp: 2028-02-20→ Common Stock (13,000 underlying) - 13,800
Non-Qualified Stock Option (right to buy)
Exercise: $50.94From: 2021-02-18Exp: 2030-02-18→ Common Stock (13,800 underlying)
Footnotes (6)
- [F1]The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020).
- [F2]The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
- [F3]The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
- [F4]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 16, 2021), respectively.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
- [F6]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively.